The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)

Bibliographic Details
Main Authors:	Wittkowski H, Kallinich T, Keitzer R, Roth J, Foell D
Format:	Article
Language:	English
Published:	BMC 2008-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

The TLR4 ligands MRP8 and MRP14 in the diagnosis and pathogenesis of systemic onset juvenile idiopathic arthritis
by: Frosch M, et al.
Published: (2008-09-01)

SERUM LEVELS OF MYELOID-RELATED PROTEIN MRP 8/14 (CALPROTECTIN) IN ARMENIAN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF)
by: Z T Dzhndoyan
Published: (2012-06-01)

Familial Mediterranean fever (FMF) in Iran
by: Farhad Salehzadeh, et al.
Published: (2016-04-01)

Updates on the role of epigenetics in familial mediterranean fever (FMF)
by: Ahlam Chaaban, et al.
Published: (2024-02-01)

Familial Mediterranean Fever (FMF) before the age of one year
by: Delion F, et al.
Published: (2008-09-01)

High prolidase levels in patients with Familial Mediterranean Fever (FMF)
by: Bayram Meliha, et al.
Published: (2020-03-01)

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
by: Georges El Hasbani, et al.
Published: (2019-10-01)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
by: Vitale A, et al.
Published: (2008-09-01)

Dimethylaminoparthenolide (DMAPT) as an alternative approach for treatment of Familial Mediterranean Fever (FMF)
by: Ali Mosayebian, et al.
Published: (2021-10-01)

Behçet Disease (BD) in two siblings affected with Familial Mediterranean Fever (FMF)
by: Calcagno G, et al.
Published: (2008-09-01)

Gut Microbiota between Environment and Genetic Background in Familial Mediterranean Fever (FMF)
by: Agostino Di Ciaula, et al.
Published: (2020-09-01)

Familial Mediterranean Fever (FMF) and renal disease: first report on 29 Sicilian patients
by: Vitale A, et al.
Published: (2008-09-01)

Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF)
by: Kerem Fidan, et al.
Published: (2015-11-01)

FMF is not always “fever”: from clinical presentation to “treat to target”
by: Maria Cristina Maggio, et al.
Published: (2020-01-01)

Phagocytic cell death leads to enhanced release of pro-inflammatory S100A12 in familial Mediterranean fever
by: G. Varga, et al.
Published: (2023-12-01)

Chronic destructive arthritis as an isolated symptom of familial Mediterranean fever (FMF) in a 17 year old Turkish boy
by: Horwitz AE, et al.
Published: (2011-09-01)

Gene–Dose Effect of MEFV Gain-of-Function Mutations Determines ex vivo Neutrophil Activation in Familial Mediterranean Fever
by: Iris Stoler, et al.
Published: (2020-06-01)

Familial Mediterranean Fever (FMF): Mysterious Presentations and Challenging Points From Diagnosis to Management in Acute Care Settings; A Literature Review
by: Soleyman Heydari, et al.
Published: (2019-12-01)

Awareness of FMF among Caregivers
by: Belde Kasap Demir, et al.
Published: (2021-12-01)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
by: Reiff AO, et al.
Published: (2011-09-01)

Diagnostic value of 18F-FDG-PET and PET-CT in children with fever of unknown origin or unexplained signs of inflammation
by: Däbritz J, et al.
Published: (2008-09-01)

Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory Conditions
by: Judith Austermann, et al.
Published: (2014-12-01)

Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory Conditions
by: Judith Austermann, et al.
Published: (2015-05-01)

Treat-to-target strategies for the management of familial Mediterranean Fever in children
by: Lisa Ehlers, et al.
Published: (2023-09-01)

The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
by: Skubitz Keith M, et al.
Published: (2005-09-01)

Evaluation of serum calprotectin (MRP-8/MRP-14) levels in patients with juvenile idiopathic arthritis
by: Tetiana Marushko, et al.
Published: (2021-03-01)

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation
by: Nicholas Dopkins, et al.
Published: (2023-02-01)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
by: Bilginer Y, et al.
Published: (2008-09-01)

Mediterranean Spotted Fever: A Review of 14 Cases
by: Ali MERT, et al.
Published: (2003-06-01)

Expression of MRP8/MRP14mRNAin Monocytes of Periodontitis: Comparison between Diabetic and Non Diabetic Patients
by: Perpustakaan UGM, i-lib
Published: (2010)

Calprotectin mRNA (MRP8/MRP14) expression in neutrophils of periodontitis patients with type 2 diabetes mellitus
by: Ahmad Syaify, et al.
Published: (2009-09-01)

Diagnostic and Prognostic Value of Calprotectin (MRP8/MRP14) in the Blood of Patients with Different Types of Juvenile Idiopathic Arthritis
by: Ya.Ye. Boiko
Published: (2016-10-01)

Investigation on Beam Expansion Method for Weakly-Coupled FMF Connections
by: Ruiting Cheng, et al.
Published: (2023-01-01)

Screening for Fabry’s disease in a high-risk subpopulation of FMF
by: Tomer Maller, et al.
Published: (2022-10-01)

MRP+ : the adaptation, enhancement, and application of MRP II /
by: 318305 Turbide, David A.
Published: (1993)

TLR3-Dependent Activation of TLR2 Endogenous Ligands via the MyD88 Signaling Pathway Augments the Innate Immune Response
by: Hellen S. Teixeira, et al.
Published: (2020-08-01)

Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel
by: Yanrong Ma, et al.
Published: (2023-10-01)

Frequency of depression, anxiety, and fatigue in fmf patients and their association with disease parameters
by: Sinem Sag, et al.
Published: (2018-12-01)

Early Disease Onset and Arthritis are Predictors of CKD Development in FMF Patients
by: Refika Büberci, et al.
Published: (2022-07-01)

Challenges and insights raised by comorbidity with FMF and selective IgA deficiency
by: Leonardo Oliveira Mendonça, et al.
Published: (2021-12-01)